Jak2/Stat5 Signaling in Mammogenesis, Breast Cancer Initiation and Progression
✍ Scribed by Kay-Uwe Wagner; Hallgeir Rui
- Publisher
- Springer US
- Year
- 2008
- Tongue
- English
- Weight
- 237 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1083-3021
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Although it is well known that Wnt and protein kinase C (PKC) signaling pathways are both involved in carcinogenesis and tumor progression, their synergistic contribution to these processes or the crosstalk between them has just recently been approached. The Wnt and PKC signaling are in
bicytopenia (anemia and thrombocytopenia). She is again transfusion dependent and on H1 and H2 blockers. Conclusion: Cladribine therapy is efficient in patient with systemic mastocytosis but response is transient so there is need for new therapy options in this rare hematologic disease. P110 Defect
We observed previously that each of seven cancer progression inhibitors suppresses the mRNA expression of some matrix metalloproteinases (MMPs), but stimulates that of others, in breast cancer cells. In the present study we tested the effect of overexpressing other cancer modulators on MMP expressio
## Abstract Aberrant janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling is involved in the oncogenesis of several cancers. Suppressors of cytokine signaling (SOCS) genes and SH2‐containing protein tyrosine phosphatase 1 (SHP1) proteins, which are negative regulator